Human Tripeptidyl-Peptidase I/TPP1 Antibody
R&D Systems, part of Bio-Techne | Catalog # AF2237
Key Product Details
Species Reactivity
Applications
Label
Antibody Source
Product Specifications
Immunogen
Ser20-Pro563
Accession # O14773
Specificity
Clonality
Host
Isotype
Applications for Human Tripeptidyl-Peptidase I/TPP1 Antibody
Immunoprecipitation
Sample: Conditioned cell culture medium spiked with Recombinant Human Tripeptidyl‑Peptidase I/TPP1, see our available Western blot detection antibodies
Western Blot
Sample: Recombinant Human Tripeptidyl‑Peptidase I/TPP1
Formulation, Preparation, and Storage
Purification
Reconstitution
Formulation
Shipping
Stability & Storage
- 12 months from date of receipt, -20 to -70 °C as supplied.
- 1 month, 2 to 8 °C under sterile conditions after reconstitution.
- 6 months, -20 to -70 °C under sterile conditions after reconstitution.
Background: Tripeptidyl-Peptidase I/TPP1
Tripeptidyl-peptidase I (TPP1), also known as CLN2, is a lysosomal serine protease detected in all tissues examined, with highest levels shown in heart and placenta. It is an aminopeptidase that cleaves tripeptides from the free N-terminus of polypeptides and may also have endopeptidase activity. Defects in TPP1 are the cause of classical late-infantile neuronal ceroid lipofusionosis, also known as ceroid lipofusionosis neuronal 2 (CLN2), a fatal childhood neurodegenerative disease characterized by progressive visual and mental decline, motor disturbance, epilepsy, and behavioral changes.
Alternate Names
Entrez Gene IDs
Gene Symbol
UniProt
Additional Tripeptidyl-Peptidase I/TPP1 Products
Product Documents for Human Tripeptidyl-Peptidase I/TPP1 Antibody
Product Specific Notices for Human Tripeptidyl-Peptidase I/TPP1 Antibody
For research use only